Subject(s)
Antineoplastic Agents/pharmacology , Gene Expression Regulation, Neoplastic , NF-kappa B/genetics , Nitriles/pharmacology , Oncogene Proteins, Fusion/genetics , Precursor T-Cell Lymphoblastic Leukemia-Lymphoma/genetics , Sulfones/pharmacology , Adolescent , Animals , Apoptosis/drug effects , Cell Cycle/drug effects , Child , Coculture Techniques , Graft Survival , Humans , Mice , Mice, SCID , NF-kappa B/antagonists & inhibitors , NF-kappa B/metabolism , Oncogene Proteins, Fusion/metabolism , Phenotype , Precursor T-Cell Lymphoblastic Leukemia-Lymphoma/metabolism , Precursor T-Cell Lymphoblastic Leukemia-Lymphoma/pathology , Prognosis , Signal Transduction , Stromal Cells/cytology , Stromal Cells/metabolism , T-Lymphocytes/metabolism , T-Lymphocytes/pathology , Transplantation, Heterologous , Xenograft Model Antitumor Assays , Young AdultSubject(s)
Lymphoma, B-Cell/diagnosis , Pituitary Neoplasms/diagnosis , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Cerebrospinal Fluid/cytology , Child , Diagnosis, Differential , Humans , Immunocompetence , Lymphoma, B-Cell/drug therapy , Lymphoma, B-Cell/pathology , Magnetic Resonance Imaging , Male , Pituitary Gland , Pituitary Neoplasms/drug therapy , Pituitary Neoplasms/pathology , Spinal PunctureABSTRACT
OBJECTIVE: To evaluate the frequency of headache in patients with hypothyroidism. DESIGN: A prospective study of a cohort of patients with hypothyroidism. SETTING: Outpatients or inpatients in a headache clinic and endocrinological clinic. PATIENTS: 102 adults, ages 35 to 78 (83F, 19M) experiencing clinical and biological hypothyroidism. RESULTS: Thirty-one patients with hypothyroidism of 102 (30%) presented with headache 1 to 2 months after the first symptoms of hypothyroidism. The headache was slight, nonpulsatile, continuous, bilateral, and salicylate responsive and disappeared with thyroid hormone therapy. CONCLUSION: The authors believe there is a prevalence of nonspecific headache in hypothyroidism and that it has a particular response to thyroid hormone therapy. Hypothyroidism is another cephalalgia with an endocrinological cause after menstrual cephalalgia. We suspect a metabolic or vascular pathophysiological process.
Subject(s)
Headache/drug therapy , Hypothyroidism/drug therapy , Thyroid Hormones/therapeutic use , Adult , Aged , Female , France/epidemiology , Headache/complications , Headache/epidemiology , Humans , Hypothyroidism/complications , Male , Middle Aged , Prevalence , Prospective Studies , Treatment OutcomeABSTRACT
The association between Graves' disease and autoimmune thrombocytopenic purpura is rare and yet more frequent than would be expected from a mere coincidence. The existence of an immunological disorder common to Graves' disease and autoimmune thrombocytopenic purpura and/or a direct responsibility of hyperthyroidism in the genesis of immunological disturbances resulting in autoimmune thrombocytopenic purpura are hypotheses put forward to try and explain why these two pathologies are associated. We report two cases in which the antiplatelet autoimmunity developed independently of the thyroid functional disorder, making it unlikely that hyperthyroidism played a direct role in the occurrence of the immunological disorders responsible for the autoimmune thrombocytopenic purpura. The physiopathology responsible for the Graves' disease-autoimmune thrombocytopenic purpura association remains imperfectly known. The existence of an immunological pathogenetic mechanism underlying both diseases seems to be likely; it probably acts through an antigenic determinant that is common to thyroid cells and platelets.
